154 related articles for article (PubMed ID: 19268647)
21. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
22. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study.
Lee IT; Chiu YF; Hwu CM; He CT; Chiang FT; Lin YC; Assimes T; Curb JD; Sheu WH
Cardiovasc Diabetol; 2012 Apr; 11():43. PubMed ID: 22537054
[TBL] [Abstract][Full Text] [Related]
23. Ethnic differences in cross-sectional associations between impaired glucose regulation, identified by oral glucose tolerance test or HbA1c values, and cardiovascular disease in a cohort of European and South Asian origin.
Eastwood SV; Tillin T; Mayet J; Shibata DK; Wright A; Heasman J; Beauchamp N; Forouhi NG; Hughes AD; Chaturvedi N
Diabet Med; 2016 Mar; 33(3):340-7. PubMed ID: 26314829
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide linkage scan for the metabolic syndrome: the GENNID study.
Edwards KL; Hutter CM; Wan JY; Kim H; Monks SA
Obesity (Silver Spring); 2008 Jul; 16(7):1596-601. PubMed ID: 18421265
[TBL] [Abstract][Full Text] [Related]
25. The Association of Type 2 Diabetes Loci Identified in Genome-Wide Association Studies with Metabolic Syndrome and Its Components in a Chinese Population with Type 2 Diabetes.
Kong X; Zhang X; Xing X; Zhang B; Hong J; Yang W
PLoS One; 2015; 10(11):e0143607. PubMed ID: 26599349
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular disease in relation to diabetes status in immigrants from the Middle East compared to native Swedes: a cross-sectional study.
Bennet L; Agardh CD; Lindblad U
BMC Public Health; 2013 Dec; 13():1133. PubMed ID: 24308487
[TBL] [Abstract][Full Text] [Related]
27. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study.
Tillin T; Forouhi N; Johnston DG; McKeigue PM; Chaturvedi N; Godsland IF
Diabetologia; 2005 Apr; 48(4):649-56. PubMed ID: 15759110
[TBL] [Abstract][Full Text] [Related]
28. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.
Sone H; Mizuno S; Fujii H; Yoshimura Y; Yamasaki Y; Ishibashi S; Katayama S; Saito Y; Ito H; Ohashi Y; Akanuma Y; Yamada N;
Diabetes Care; 2005 Jun; 28(6):1463-71. PubMed ID: 15920069
[TBL] [Abstract][Full Text] [Related]
29. Cardiometabolic disease in South Asians: A global health concern in an expanding population.
Das A; Ambale-Venkatesh B; Lima JA; Freedman JE; Spahillari A; Das R; Das S; Shah RV; Murthy VL
Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):32-40. PubMed ID: 27612985
[TBL] [Abstract][Full Text] [Related]
30. Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the UK Biobank population-based cohort study.
Muilwijk M; Ho F; Waddell H; Sillars A; Welsh P; Iliodromiti S; Brown R; Ferguson L; Stronks K; van Valkengoed I; Pell JP; Gray SR; Gill JMR; Sattar N; Celis-Morales C
BMJ Open Diabetes Res Care; 2019; 7(1):e000765. PubMed ID: 31908795
[TBL] [Abstract][Full Text] [Related]
31. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study.
Doi Y; Ninomiya T; Hata J; Yonemoto K; Arima H; Kubo M; Tanizaki Y; Iwase M; Iida M; Kiyohara Y
Stroke; 2009 Apr; 40(4):1187-94. PubMed ID: 19265058
[TBL] [Abstract][Full Text] [Related]
32. The influence of family history of hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults.
Ranasinghe P; Cooray DN; Jayawardena R; Katulanda P
BMC Public Health; 2015 Jun; 15():576. PubMed ID: 26092387
[TBL] [Abstract][Full Text] [Related]
33. VDR Gene variation and insulin resistance related diseases.
Han FF; Lv YL; Gong LL; Liu H; Wan ZR; Liu LH
Lipids Health Dis; 2017 Aug; 16(1):157. PubMed ID: 28822353
[TBL] [Abstract][Full Text] [Related]
34. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H
Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study.
Stojisavljević D; Janković J; Erić M; Marinković J; Janković S
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):568-574. PubMed ID: 29097061
[TBL] [Abstract][Full Text] [Related]
36. A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome.
Li J; Bergmann A; Reimann M; Bornstein SR; Schwarz PE
Horm Metab Res; 2009 Feb; 41(2):98-103. PubMed ID: 18975253
[TBL] [Abstract][Full Text] [Related]
37. Elevation in cardiovascular disease risk in South Asians is mediated by differences in visceral adipose tissue.
Lear SA; Chockalingam A; Kohli S; Richardson CG; Humphries KH
Obesity (Silver Spring); 2012 Jun; 20(6):1293-300. PubMed ID: 22282045
[TBL] [Abstract][Full Text] [Related]
38. Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.
Webb DR; Khunti K; Srinivasan B; Gray LJ; Taub N; Campbell S; Barnett J; Henson J; Hiles S; Farooqi A; Griffin SJ; Wareham NJ; Davies MJ
Trials; 2010 Feb; 11():16. PubMed ID: 20170482
[TBL] [Abstract][Full Text] [Related]
39. Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes.
Katakami N; Kaneto H; Matsuoka TA; Takahara M; Maeda N; Shimizu I; Ohno K; Osonoi T; Kawai K; Ishibashi F; Imamura K; Kashiwagi A; Kawamori R; Matsuhisa M; Funahashi T; Yamasaki Y; Shimomura I
Atherosclerosis; 2012 Feb; 220(2):437-42. PubMed ID: 22138143
[TBL] [Abstract][Full Text] [Related]
40. Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors.
Walker SE; Gurka MJ; Oliver MN; Johns DW; DeBoer MD
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):141-8. PubMed ID: 20708390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
